GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FullHope Biomedical Co Ltd (ROCO:7773) » Definitions » Price-to-Owner-Earnings

FullHope Biomedical Co (ROCO:7773) Price-to-Owner-Earnings : (As of May. 29, 2025)


View and export this data going back to 2024. Start your Free Trial

What is FullHope Biomedical Co Price-to-Owner-Earnings?

As of today (2025-05-29), FullHope Biomedical Co's share price is NT$38.00. FullHope Biomedical Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for FullHope Biomedical Co's Price-to-Owner-Earnings or its related term are showing as below:


ROCO:7773's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-29), FullHope Biomedical Co's share price is NT$38.00. FullHope Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-1.43. Therefore, FullHope Biomedical Co's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-29), FullHope Biomedical Co's share price is NT$38.00. FullHope Biomedical Co's EPS without NRI for the trailing twelve months (TTM) ended in was NT$-1.43. Therefore, FullHope Biomedical Co's PE Ratio without NRI for today is At Loss.


FullHope Biomedical Co Price-to-Owner-Earnings Historical Data

The historical data trend for FullHope Biomedical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FullHope Biomedical Co Price-to-Owner-Earnings Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - - -

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of FullHope Biomedical Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, FullHope Biomedical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FullHope Biomedical Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where FullHope Biomedical Co's Price-to-Owner-Earnings falls into.


;
;

FullHope Biomedical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

FullHope Biomedical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=38.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FullHope Biomedical Co  (ROCO:7773) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


FullHope Biomedical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of FullHope Biomedical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


FullHope Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.

FullHope Biomedical Co Headlines

No Headlines